SJS Investment Consulting »

Monte Rosa Therapeutics shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2025-12-31 $455 29 15.69

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust Short Duration F (DFSD)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Us Eqt Etf (AVUS)
Hormel Foods Corporation (HRL)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Dimensional Etf Trust World Ex Us Core (DFAX)
NVIDIA Corporation (NVDA)

View all positions for SJS Investment Consulting

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics